-
1
-
-
0030769165
-
The role of TNF-α and related cytokines in the development and function of the autoreactive T-cell repertoire
-
Cope A, Ettinger R, McDevitt H (1997) The role of TNF-α and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 148: 307-312
-
(1997)
Res Immunol
, vol.148
, pp. 307-312
-
-
Cope, A.1
Ettinger, R.2
McDevitt, H.3
-
2
-
-
0034254254
-
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes
-
Raza A (2000) Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes. Microsc Res Tech 50: 229-235
-
(2000)
Microsc Res Tech
, vol.50
, pp. 229-235
-
-
Raza, A.1
-
3
-
-
0033524159
-
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
-
ATTRACT Study Group
-
Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet 354: 1932-1939
-
(1999)
Lancet
, vol.354
, pp. 1932-1939
-
-
Maini, R.1
St Clair, E.W.2
Breedveld, F.3
Furst, D.4
Kalden, J.5
Weisman, M.6
Smolen, J.7
Emery, P.8
Harriman, G.9
Feldmann, M.10
Lipsky, P.11
-
4
-
-
0029316962
-
Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors
-
Selmaj KW, Raine CS (1995) Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45: S44-S49
-
(1995)
Neurology
, vol.45
-
-
Selmaj, K.W.1
Raine, C.S.2
-
6
-
-
0025852567
-
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
-
Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-954
-
(1991)
J Clin Invest
, vol.87
, pp. 949-954
-
-
Selmaj, K.1
Raine, C.S.2
Cannella, B.3
Brosnan, C.F.4
-
7
-
-
0025773147
-
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
-
Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467-472
-
(1991)
N Engl J Med
, vol.325
, pp. 467-472
-
-
Sharief, M.K.1
Hentges, R.2
-
8
-
-
0029751983
-
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
-
van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534
-
(1996)
Neurology
, vol.47
, pp. 1531-1534
-
-
van Oosten, B.W.1
Barkhof, F.2
Truyen, L.3
Boringa, J.B.4
Bertelsmann, F.W.5
von Blomberg, B.M.6
Woody, J.N.7
Hartung, H.P.8
Polman, C.H.9
-
9
-
-
0033546665
-
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
-
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group
-
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53: 457-465
-
(1999)
Neurology
, vol.53
, pp. 457-465
-
-
-
10
-
-
0035960624
-
Onset of multiple sclerosis associated with anti-TNF therapy
-
Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57: 1885-1888
-
(2001)
Neurology
, vol.57
, pp. 1885-1888
-
-
Sicotte, N.L.1
Voskuhl, R.R.2
-
11
-
-
0035674613
-
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
-
Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44: 2862-2869
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2862-2869
-
-
Mohan, N.1
Edwards, E.T.2
Cupps, T.R.3
Oliverio, P.J.4
Sandberg, G.5
Crayton, H.6
Richert, J.R.7
Siegel, J.N.8
-
12
-
-
0035464263
-
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: By what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
-
Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: By what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44: 1977-1983
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1977-1983
-
-
Robinson, W.H.1
Genovese, M.C.2
Moreland, L.W.3
|